Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Visit

EHA 2021 | Risk factors and outcomes of Klebsiella pneumoniae infection before and after allo-HCT

Eleni Gavriilaki • 26 May 2021

EHA 2021

General

Eleni Gavriilaki, MD, PhD, National and Kapodistrian University of Athens, Athens, Greece, gives an overview of a study of the risk factors and outcomes of Klebsiella pneumoniae infection before and after allogeneic hematopoietic cell transplant (allo-HCT). Dr Gavriilaki reports that allo-HCT is feasible in patients with Klebsiella pneumoniae, however infection impairs survival outcomes. Patients who had a Klebsiella pneumoniae infection prior to allo-HCT were found to be more likely to develop an infection after allo-HCT, and this was independently associated with the presence of graft-versus-host disease. This interview took place at the virtual European Hematology Association (EHA) Congress 2021.

Disclosures

Eleni Gavriilaki, MD, PhD, has participated in consultancy work with Alexion and Omeros Corporation.

Agents under investigation for the treatment of TA-TMA

Eleni Gavriilaki • 16 Feb 2024

Cognitive impairment in patients receiving CAR T-cell therapy

Eleni Gavriilaki • 16 Feb 2024

Long-term complications in patients with hematological malignancies post-SCT

Eleni Gavriilaki • 11 Dec 2023

The potential of caplacizumab in the treatment of aTTP

Eleni Gavriilaki • 11 Dec 2023

Related Videos

The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024

Natacha Bolaños • 16 Apr 2024

Distinguishing late-onset neutropenia from classical primary neutropenia

Carlo Dufour • 15 Apr 2024

The MAGIC algorithm probability to predict outcomes of GvHD in the GI tract

James Ferrara • 16 Apr 2024

The EBMT Trainee Committee: in-person trainee day at EBMT 2024 and upcoming initiatives

Claire Horgan • 15 Apr 2024